Standard Engineering Share Price

Standard Glass Lining Technology Limited (Standard Glass Lining) is a specialized engineering equipment manufacturer in India, primarily engaged in the design, manufacture, and supply of glass-lined equipment for the pharmaceutical and chemical industries. The company supplies reaction systems, storage/separation/drying systems, and turnkey engineering services to pharmaceutical and chemical clients across India and internationally. Standard Glass Lining Technology share price on the NSE and BSE is a reflection of how market participants respond to a performance and broader business developments within its industry. It captures the company’s sentiment of the investors based on financial results, operational updates, macroeconomic factors, and trends specific to sectors. Movements in the share price͏ reveal how the market evaluates the company’s current position and its future prospects, making ͏it a key indicator of market perception across various industries.

Market sentiment around the Standard Glass Lining Technology stock price often mirrors shifts in pharmaceutical manufacturing spending, demand from the API and fine chemical sectors, and investor views on the capital goods sector’s growth prospects. Factors such as the pace of order book expansion, competitive intensity from other equipment manufacturers, raw material price fluctuations, and government policies on pharmaceutical manufacturing influence near-term market valuation and medium-term earnings forecasts. All these factors must be closely monitored to have an idea about the Standard Glass Lining Technology stock price movements.

Standard Glass Lining Technology live share price provides real-time information about the last price traded, bid price, ask price, and volume traded. These indicators represent trading activity and liquidity and the reaction of investors to corporate announcements, quarterly results, and sector news. Constant monitoring of Standard Glass Lining Technology live price helps observe short-term price fluctuations and understand how the stock is moving in relation to the broader market.

Furthermore, monitoring the Standard Glass Lining Technology share price today helps investors understand real-time market sentiment, price volatility, and trading behaviour. It allows market participants to evaluate short-term performance, identify possible entry or exit points, and respond to news, quarterly results or sector trends that may affect the company’s valuation and overall investment outlook.

Standard Glass Lining Technology Limited Company Fundamentals

a. Company Background

Standard Glass Lining Technology Limited was incorporated in 2012. The company’s registered office is located in Hyderabad, Telangana. The company was incorporated as ‘Standard Glass Lining Technology Private Limited’ on September 6, 2012, and subsequently the name was changed to Standard Glass Lining Technology Limited with a fresh Certificate of Incorporation dated June 17, 2022. The company’s primary activity involves the manufacturing and selling of glass-lined reactors, receivers, and storage tanks, and is specialized in providing turnkey solutions for the pharmaceutical industry sector. It initially focused on establishing glass-lined equipment manufacturing capabilities before gradually expanding into stainless steel and nickel alloy-based specialized engineering equipment. The company acquired the Glass Lining Division in 2013, sold 100 glass-lined reactors in 2014, and supplied a stainless steel glass-lined reactor to Natco Pharma Limited in 2016. Standard Glass Lining Technology supplies reaction systems, storage/separation/drying systems, plant engineering and services, and other ancillary parts to the pharmaceutical and chemical industries. Over the years, the company has significantly expanded its manufacturing capacity, now operating eight manufacturing facilities across Hyderabad. It is one of India’s top three manufacturers of glass-lined, stainless steel, and nickel alloy-based specialized engineering equipment. The company has entered into an exclusive collaboration with GL Hakko for manufacturing and selling shell and heat tube exchangers in India and abroad except Japan. It also has a supply and purchase arrangement with Japan-based Asahi Glass plant Inc. and GL Hakko Co. for procurement of specified grades of glass for its glass lining division.

b. Product Lines

• Reaction systems including glass-lined reactors for pharmaceutical and chemical manufacturing processes

• Storage, separation, and drying systems (SSD Systems) including receivers and storage tanks

• Plant, engineering, and services including other ancillary parts

• Glass-lined shell and tube heat exchangers launched in FY2025

• Stainless steel and nickel alloy-based specialized engineering equipment

• PTFE lined equipment for chemical processing applications

• Metal equipment and pumps including metalworking machinery

• Automatic sampler system pressurized and atmospheric equipment

• Solvent recovery and powder transfer systems

• Baffles, thermowell dip pipes, smart seals, stanbalancers, anchors, propellers, turbofoil cryofix, and accessories

• Advanced glass technology, material traceability, and enamel spraying services

• Assembly, testing, and dispatch services

• Installation and commissioning, and repair and refurbishing services

c. Company Revenue Model

• Primary revenue from design, manufacture, and sale of reaction systems (glass-lined reactors) which contributed 56.71% of revenue in FY2025

• Revenue from storage, separation, and drying (SSD) systems which contributed 30.08% of revenue in FY2025

• Revenue from plant, engineering, and services including other ancillary parts which contributed 13.21% of revenue in FY2025

• Volume-driven revenue based on number of equipment units manufactured and sold to customers

• Pricing determined by engineering complexity, raw material costs (steel, glass lining materials, nickel alloy), and customer specifications

• Backward integration benefits from in-house capabilities across the entire value chain including design, engineering, manufacturing, assembly, installation, and commissioning

• Approximately 81.79% of revenue from Pharmaceuticals, 12.54% from Chemicals, and 5.67% from others in FY2024

• Turnkey automated equipment solutions revenue from optimizing processes like vacuum distillation, solvent recovery, and gas dispersion

• Revenue from both domestic sales in India and export markets

• Expanding product portfolio of more than 65 products and offerings contributing to new revenue streams

• Customer base of 347 companies as of September 30, 2024, including 30 out of approximately 80 pharmaceutical and chemical companies in the NSE 500 index

• Monthly installed capacity of 150-200 glass-lined vessels

• Seasonal variations in pharmaceutical industry capex cycles affecting revenue patterns

• Government pharmaceutical manufacturing policies and PLI schemes influencing revenue stability

d. Geographic Presence

• Headquartered in Hyderabad, Telangana with registered office at D.12, Phase-1, IDA Jeedimetla, Hyderabad – 500055

• Eight manufacturing facilities spread across Hyderabad, Telangana

• S2 Engineering Industry Private Limited, a wholly-owned subsidiary incorporated in 2021, operating additional manufacturing capacity

• Standard Engineering Inc. formed as a wholly-owned subsidiary of the Company w.e.f. June 5, 2025

• Strong domestic presence across India serving pharmaceutical and chemical clients including marquee customers such as Aurobindo Pharma, Cadila Pharmaceutical, Laurus Labs, Natco Pharma, Piramal Pharma, and Suven Pharmaceuticals

• International presence across foreign countries with revenue of ₹20.37 million from exports in FY2024

• Global collaboration with Japan-based Asahi Glass plant Inc. and GL Hakko Co. for procurement of glass

• Exclusive collaboration with GL Hakko for manufacturing glass-lined shell and tube heat exchangers

• Focus on expanding global footprint through strategic partnerships and export growth

• Operations primarily concentrated in India with growing international export presence

e. Key Milestones

• 2012: Incorporated as Standard Glass Lining Technology Private Limited on September 6, 2012

• 2013: Acquired the Glass Lining Division

• 2014: Supplied 100 glass-lined reactors

• 2016: Supplied stainless steel glass-lined reactor to Natco Pharma Limited

• 2019: Completed construction of new facility of glass lining equipment at SGL Unit

• 2021: S2 Engineering Industry Private Limited incorporated as wholly-owned subsidiary

• 2022: Name changed to Standard Glass Lining Technology Limited on June 17, 2022

• 2024: Acquired business of Hyderabad-based C.P.K. Engineers Private Limited

• 2025: IPO launched on January 6, 2025 with price range of ₹140-140, oversubscribed 183.18 times

• 2025: Listed on BSE and NSE on January 13, 2025 at a premium of 25.71% on BSE and 23% on NSE

• 2025: Name changed to Standard Engineering Technology Limited on December 29, 2025

f. Industry Perspective

Standard Glass Lining Technology Limited operates in the specialized engineering equipment manufacturing industry for pharmaceutical and chemical sectors, which is part of India’s capital goods sector. Globally, the pharmaceutical equipment market was valued at approximately USD 50 billion in 2024, with the Asia-Pacific region being the fastest-growing market, accounting for around 35% of global demand. The global glass-lined equipment market is projected to grow at a CAGR of approximately 5.5% from 2025 to 2030, driven by increasing pharmaceutical manufacturing and API production. In India, the pharmaceutical equipment market is poised for substantial growth as the nation strengthens its position as a global pharmaceutical manufacturing hub. According to industry reports, the Indian pharmaceutical equipment market was valued at USD 3.5 billion in 2024 and is projected to reach USD 7.5 billion by 2028, growing at a CAGR of 16-18% during this period. The glass-lined equipment segment constitutes approximately 25-30% of the specialized engineering equipment market in India. The Indian pharmaceutical industry, currently valued at USD 50 billion, is projected to reach USD 130 billion by 2030, creating significant demand for specialized equipment. The government aims to increase India’s share in global pharmaceutical manufacturing from 3.5% to 7% by 2030 under the Pharmaceutical PLI Scheme. The API manufacturing sector is expected to grow at 12-14% CAGR, driving demand for glass-lined reactors and associated equipment. The bulk of the Indian specialized equipment market is serviced by 5-6 major national players, with imports primarily in high-technology applications. Demand is driven by government initiatives such as the Production Linked Incentive (PLI) Scheme for Pharmaceuticals, the National Pharmaceutical Policy, the Bulk Drug Park Scheme (₹3,000 crore outlay), and increasing API manufacturing capacity. Key challenges include import competition from Chinese manufacturers, raw material price volatility, technology gaps in high-end applications, and longer approval cycles for pharmaceutical facility expansions.

Standard Glass Lining Technology Limited Stock Market Presence: Listings & Index Representation

Standard Glass Lining Technology is actively traded on India’s principal equity markets, with its shares listed on the National Stock Exchange of India (NSE) under the symbol SGLTL (NSE Code SGLTLEQ) and on the Bombay Stock Exchange (BSE) with the scrip code 544333. Its listing on both exchanges ensures that the Standard Glass Lining Technology price is accessible to a wide investor base, encompassing both retail and institutional market participants. The company was listed on the BSE and NSE on January 13, 2025 following its Initial Public Offering (IPO) from January 6-8, 2025, becoming the first mainboard IPO of 2025. The IPO was subscribed 183.18 times with total bids exceeding ₹53,000 crore. The company forms part of several benchmark indices that represent broad market segments. Standard Glass Lining Technology is included in the BSE IPO Index on the BSE. The company is listed under ‘B’ Group Securities on the BSE. Being represented in indices enhances the visibility and liquidity of the Standard Glass Lining Technology price, as index tracking funds and exchange traded strategies often adjust allocations in line with constituent revisions. It also allows investors to benchmark the company’s stock performance relative to broader market trends and peer groups, facilitating cross sectional comparisons within India’s specialized engineering equipment landscape. The inclusion of Standard Glass Lining Technology in these indices reflects its market capitalisation and trading depth, which are key factors market participants consider when evaluating long term investment prospects and the responsiveness of the Standard Glass Lining Technology price to corporate and industry developments. The company’s ISIN code is INE0M4D01010 and face value is ₹10 per share.

Standard Glass Lining Technology Limited Stock Performance and Share Price History

The Standard Glass Lining Technology price has exhibited significant volatility since its listing in January 2025, shaped by the company’s position in India’s specialized engineering equipment sector and broader capital goods industry cycles. The Standard Glass Lining Technology share price recorded a negative total return of approximately 11.56% over the last 1 year, underperforming broader market indices and reflecting near-term headwinds including valuation compression post-IPO. The Standard Glass Lining Technology share price has delivered returns showing significant fluctuations since its debut. The Standard Glass Lining Technology share price reached a 52-week high of 213.80 and a 52-week low of 104.75, indicating a wide trading range and substantial price fluctuations. The Standard Glass Lining Technology share price recorded a strong listing day debut, listing at ₹176 on BSE (25.71% premium) and ₹172 on NSE (23% premium) against the issue price of ₹140. The Standard Glass Lining Technology stock price subsequently rallied to its all-time high of 213.80 before moderating to current levels. The Standard Glass Lining Technology share price has shown a 1-month return of approximately 13.29% and a 3-month return of 6.88%, indicating recent recovery from lows.

The Standard Glass Lining Technology stock price has been particularly responsive to quarterly earnings releases and corporate announcements. When the company reported a 14.4% year-on-year growth in net profit to ₹68.6 crore in FY2025, the Standard Glass Lining Technology stock price showed a positive reaction. The Standard Glass Lining Technology share price has shown a pattern of volatility with periods of positive momentum when earnings exceed expectations, while periods of earnings moderation have contributed to consolidation in the Standard Glass Lining Technology stock price. Corporate developments, including strategic announcements such as the name change to Standard Engineering Technology Limited on December 29, 2025, the planned ₹240 crore investment in a new manufacturing facility at Jinnaram, and the expansion into PTFE lined equipment and stainless steel/nickel alloy manufacturing, have also influenced short-term fluctuations in the Standard Glass Lining Technology share price. The Standard Glass Lining Technology share price has shown a 5-year return that cannot be fully calculated due to the company’s recent listing in 2025. The Standard Glass Lining Technology share price reached its 52-week high of 213.80 before declining to its 52-week low of 104.75, reflecting the volatility inherent in the specialized engineering equipment distribution space. The Standard Glass Lining Technology share price has shown a year-to-date return of -5.85% as of April 2026, indicating continued pressure in the current fiscal year. Comprehending these patterns in the Standard Glass Lining Technology share price is instrumental for investors seeking to contextualise long term performance trends vis à vis short term price dynamics, as the Standard Glass Lining Technology stock price movements illustrate how industry fundamentals, raw material price cycles, and investor expectations converge in market pricing.

The Standard Glass Lining Technology price has shown distinct seasonal patterns since its listing. The best performing period historically was the listing day debut in January 2025 with a premium of 25.71%, while the worst period was the subsequent correction to the 52-week low of 104.75. In terms of annual performance, the Standard Glass Lining Technology price delivered its strongest performance on listing day in January 2025, while the stock recorded negative returns in the subsequent months. The Standard Glass Lining Technology share price has shown a 1-year return of -11.56% according to some sources, while the stock has shown a beta of 1.91 indicating higher volatility compared to the market. The Standard Glass Lining Technology price has demonstrated that the stock tends to perform better in periods of strong pharmaceutical capex spending and supportive government policies, while underperforming during phases of raw material inflation and intense competition. The Standard Glass Lining Technology price has shown continued moderate performance in the current trading period, reflecting the steady demand in the pharmaceutical equipment sector. The Standard Glass Lining Technology stock price has shown a 52-week range of 104.75-213.80, with a current market capitalization of approximately ₹25,325-30,670 million depending on the source.

Standard Glass Lining Technology Limited Investor Relevance and Role in Portfolio

Standard Glass Lining Technology holds a growing position for portfolio investors who seek exposure to India’s specialized engineering equipment sector with a focus on the pharmaceutical manufacturing segment. The company’s strong presence in glass-lined reactors, storage/separation/drying systems, and turnkey engineering services aligns it with investment strategies that value pharmaceutical infrastructure and domestic API manufacturing. The Standard Glass Lining Technology share price often mirrors how these themes resonate with investor portfolios, whereby both thematic and sector specific funds monitor pharmaceutical capex indicators and order book expansion factors when evaluating allocation decisions.

Institutional stakeholders play a growing role in Standard Glass Lining Technology’s ownership profile, with notable long term investment entities such as promoters holding 60.41-60.47%, Foreign Institutional Investors (FIIs) holding 2.41-2.54%, Mutual Funds holding 0.54-1.97%, and Other Institutional Investors holding 2.48% among key shareholders identified in institutional holdings data as of December 2025. Mutual fund holders of Standard Glass Lining Technology encompass those that seek capital goods and pharmaceutical equipment exposure. The Standard Glass Lining Technology share price has shown institutional participation, with total institutional holding at approximately 3.29% to 4.84% depending on the quarter. The Standard Glass Lining Technology stock price’s beta reflects that the company’s specialized engineering nature and established customer relationships may provide some stability, though the capital goods sector remains sensitive to economic cycles and raw material price fluctuations.

Based on data, Standard Glass Lining Technology exhibits varying levels of beta and volatility across different measurement periods. The long-term beta stands at 1.91, indicating that the stock is significantly more volatile than the broader market over an extended period. Based on data, the daily-one month beta shows higher sensitivity than the market, while the daily-three month beta indicates elevated volatility. The weekly-one year beta shows above-market sensitivity. Based on data, the weekly-two year beta shows moderate fluctuations. Supporting statistics include mean values across different periods: 52-week high of 213.80 and 52-week low of 104.75, with the stock currently trading near the lower end of this range. Standard deviations across periods are relatively high due to the stock’s recent listing and post-IPO volatility. Based on data, the stock has a beta of 1.91, indicating it is more volatile than the market, with a 1-year volatility that remains elevated compared to the industry average. Overall, Standard Glass Lining Technology demonstrates a high volatility profile with beta values suggesting the stock tends to move with significantly higher sensitivity compared to broader market direction, reflecting the stock’s recent listing and developing price history.

Standard Glass Lining Technology Limited Sectoral Relevance and Peer Positioning

The sector relevance of Standard Glass Lining Technology is anchored in its role within the broader Indian specialized engineering equipment manufacturing industry for pharmaceutical and chemical sectors, where it competes with other equipment manufacturers. As part of this industry, the company’s strategic positioning connects glass-lined reactors, storage systems, and turnkey engineering services for pharmaceutical API manufacturing and fine chemical production. Competitors in the specialized engineering equipment segment include companies such as GMM Pfaudler Limited (HINDNATGLS), Jocil Limited, Madhucon Projects Limited, Orient Paper & Industries Ltd, and other specialized equipment manufacturers. Firms with parallels in either product portfolio scale or customer reach are often referenced when evaluating relative performance and operational positioning within the sector.

In valuation terms, factors like the Standard Glass Lining Technology P/E ratio have shown variations over different periods. The mean historical PE Ratio since listing has varied significantly, with the current P/E ratio of 39.2 to 43.1 having changed with respect to the historical average. Periods when investors perceived improvements in profitability or earnings sustainability have corresponded with expansion in valuation multiples, whereas phases of moderation in earnings momentum have seen valuation contraction. Standard Glass Lining Technology earnings have shown a trajectory of consistent growth over the analysed period, responding to both volume growth and margin improvements. Standard Glass Lining Technology market cap has fluctuated in line with investor perceptions of the company’s growth potential in a competitive and evolving specialized engineering equipment market.

Over years, the Standard Glass Lining Technology market cap has followed a pattern of growth following its IPO in January 2025. From its listing, the company’s market cap showed an initial increase, reflecting strong investor confidence following the successful IPO. The market cap increased from approximately ₹28.00 billion at IPO listing to a peak of ₹30.67-34.49 billion in subsequent months, before moderating to approximately ₹25.33-26.46 billion in recent periods. As of recent data, market capitalization stands at approximately ₹25,325-30,670 million depending on the source. This fluctuation reflects the volatility in the Standard Glass Lining Technology share price and the broader performance of the capital goods sector.

Standard Glass Lining Technology earnings over the past four years has been characterised by a period of consistent growth. Net income showed a generally increasing trend, with reported net profit rising from ₹25.15 crore in FY2022 to ₹53.42 crore in FY2023, ₹58.38 crore in FY2024, and ₹64.35 crore in FY2025 (consolidated), or ₹68.6 crore (standalone). In FY2025, profit amounted to ₹64.35-68.6 crore, a 10.2-14.4% increase from the previous year. This recent earnings growth reflects the impact of volume expansion, product mix improvement, and operational efficiencies on the company’s profitability. The company has delivered good profit growth over the last 4 years.

Standard Glass Lining Technology EPS has shown an increasing trend over the available period, indicating a strong financial track record. The diluted EPS growth rate has shown variation, with EPS of ₹1.26 in FY2022, ₹2.68 in FY2023, ₹2.93 in FY2024, and ₹3.47 in FY2025. The year-on-year growth rates show 112.7% growth in FY2023, 9.3% growth in FY2024, and 18.4% growth in FY2025. Over the four-year period, the company demonstrated consistent improvement in EPS. The TTM EPS stands at ₹3.47 to ₹3.57 as of recent data, reflecting the continued positive momentum.

The Standard Glass Lining Technology P/E ratio has shown fluctuations over the available period since listing. At the end of recent periods, the P/E ratio varied, with post-IPO P/E at 48.95 in September 2025, moderating to 43.10 in December 2025, and current P/E at 39.2. The mean historical P/E ratio over the short available period has varied significantly. The current P/E ratio stands at 39.2 compared to the industry P/E, reflecting that investor expectations are pricing in strong earnings growth ahead. The Standard Glass Lining Technology share price has been influenced by these valuation metrics. The Standard Glass Lining Technology price continues to be evaluated in the context of its earnings potential and market position.

Summary

Standard Glass Lining Technology Limited is a specialized engineering equipment manufacturer listed on both the NSE and BSE, where the Standard Glass Lining Technology share price reflects pharmaceutical capex cycles, API manufacturing trends, and order book expansion within the specialized equipment sector. Its representation on stock exchanges supports market visibility, while investor interest is shaped by earnings trends, valuation narratives, and broader pharmaceutical manufacturing themes. Within the sector, the company’s competitive context and earnings dynamics provide key perspectives on its role in India’s specialized engineering equipment market.